STEC-HUS, atypical HUS and TTP are all diseases of complement activation
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
STEC-HUS, atypical HUS and TTP are all diseases of complement activation
Authors
Keywords
-
Journal
Nature Reviews Nephrology
Volume 8, Issue 11, Pages 622-633
Publisher
Springer Nature
Online
2012-09-18
DOI
10.1038/nrneph.2012.195
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Eculizumab in the treatment of refractory idiopathic thrombotic thrombocytopenic purpura
- (2012) John Chapin et al. BRITISH JOURNAL OF HAEMATOLOGY
- Therapeutic targeting of the complement system in age-related macular degeneration: a review
- (2012) Robyn Troutbeck et al. CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY
- The CXCR4/CXCR7/SDF-1 pathway contributes to the pathogenesis of Shiga toxin–associated hemolytic uremic syndrome in humans and mice
- (2012) Tania N. Petruzziello-Pellegrini et al. JOURNAL OF CLINICAL INVESTIGATION
- Complement activation in thrombotic thrombocytopenic purpura
- (2012) M. RÉTI et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Eculizumab in the Treatment of Atypical Hemolytic Uremic Syndrome in Infants
- (2011) Gema Ariceta et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Complement activation on platelet-leukocyte complexes and microparticles in enterohemorrhagic Escherichia coli-induced hemolytic uremic syndrome
- (2011) A.-l. Stahl et al. BLOOD
- Alternative Pathway Activation of Complement by Shiga Toxin Promotes Exuberant C3a Formation That Triggers Microvascular Thrombosis
- (2011) M. Morigi et al. JOURNAL OF IMMUNOLOGY
- INF2 Is Another Piece of the Jigsaw Puzzle for FSGS
- (2011) Y. Pei JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- In patients with atypical hemolytic uremic syndrome C5 activation causes loss of endothelial thromboresistance
- (2011) M. Galbusera et al. MOLECULAR IMMUNOLOGY
- Glomerular endothelial microvascular heterogeneity and response to cytokines predispose to the development of atypical HUS
- (2011) A. Richards MOLECULAR IMMUNOLOGY
- Inhibiting the C5–C5a receptor axis
- (2011) Trent M. Woodruff et al. MOLECULAR IMMUNOLOGY
- Eculizumab in Severe Shiga-Toxin–Associated HUS
- (2011) Anne-Laure Lapeyraque et al. NEW ENGLAND JOURNAL OF MEDICINE
- Origins of theE. coliStrain Causing an Outbreak of Hemolytic–Uremic Syndrome in Germany
- (2011) David A. Rasko et al. NEW ENGLAND JOURNAL OF MEDICINE
- Epidemic Profile of Shiga-Toxin–ProducingEscherichia coliO104:H4 Outbreak in Germany
- (2011) Christina Frank et al. NEW ENGLAND JOURNAL OF MEDICINE
- Prophylactic eculizumab prior to kidney transplantation for atypical hemolytic uremic syndrome
- (2011) Marcus Weitz et al. PEDIATRIC NEPHROLOGY
- Mutations in Complement Regulatory Proteins Predispose to Preeclampsia: A Genetic Analysis of the PROMISSE Cohort
- (2011) Jane E. Salmon et al. PLOS MEDICINE
- Complement alternative pathway acts as a positive feedback amplification of neutrophil activation
- (2010) L. Camous et al. BLOOD
- The complement system
- (2010) J. Vidya Sarma et al. CELL AND TISSUE RESEARCH
- Relative Role of Genetic Complement Abnormalities in Sporadic and Familial aHUS and Their Impact on Clinical Phenotype
- (2010) M. Noris et al. Clinical Journal of the American Society of Nephrology
- Pathophysiology of thrombotic thrombocytopenic purpura
- (2010) Han-Mou Tsai INTERNATIONAL JOURNAL OF HEMATOLOGY
- Molecular Intercommunication between the Complement and Coagulation Systems
- (2010) U. Amara et al. JOURNAL OF IMMUNOLOGY
- Pregnancy-Associated Hemolytic Uremic Syndrome Revisited in the Era of Complement Gene Mutations
- (2010) F. Fakhouri et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Clinical Features of Anti-Factor H Autoantibody-Associated Hemolytic Uremic Syndrome
- (2010) M.-A. Dragon-Durey et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Complement activation on platelets: Implications for vascular inflammation and thrombosis
- (2010) Ellinor I. Peerschke et al. MOLECULAR IMMUNOLOGY
- Complement: a key system for immune surveillance and homeostasis
- (2010) Daniel Ricklin et al. NATURE IMMUNOLOGY
- Prophylactic Eculizumab after Renal Transplantation in Atypical Hemolytic–Uremic Syndrome
- (2010) Lothar Bernd Zimmerhackl et al. NEW ENGLAND JOURNAL OF MEDICINE
- Eculizumab and Renal Transplantation in a Patient with CAPS
- (2010) Bonnie E. Lonze et al. NEW ENGLAND JOURNAL OF MEDICINE
- Genetics and complement in atypical HUS
- (2010) David Kavanagh et al. PEDIATRIC NEPHROLOGY
- Genetics and Genetic Testing in Hemolytic Uremic Syndrome/Thrombotic Thrombocytopenic Purpura
- (2010) Marina Noris et al. SEMINARS IN NEPHROLOGY
- Eculizumab: Safety and Efficacy After 17 Months of Treatment in a Renal Transplant Patient With Recurrent Atypical Hemolytic-Uremic Syndrome: Case Report
- (2010) V. Châtelet et al. TRANSPLANTATION PROCEEDINGS
- Complement fraction 3 binding on erythrocytes as additional mechanism of disease in paroxysmal nocturnal hemoglobinuria patients treated by eculizumab
- (2009) A. M. Risitano et al. BLOOD
- Hyperfunctional C3 convertase leads to complement deposition on endothelial cells and contributes to atypical hemolytic uremic syndrome
- (2009) L. T. Roumenina et al. BLOOD
- Association of factor H autoantibodies with deletions of CFHR1, CFHR3, CFHR4, and with mutations in CFH, CFI, CD46, and C3 in patients with atypical hemolytic uremic syndrome
- (2009) I. Moore et al. BLOOD
- Eculizumab
- (2009) Eline A. Dubois et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Alternative Pathway of Complement in Children with Diarrhea-Associated Hemolytic Uremic Syndrome
- (2009) J. M. Thurman et al. Clinical Journal of the American Society of Nephrology
- Shiga Toxin Activates Complement and Binds Factor H: Evidence for an Active Role of Complement in Hemolytic Uremic Syndrome
- (2009) Dorothea Orth et al. JOURNAL OF IMMUNOLOGY
- The Binding of Factor H to a Complex of Physiological Polyanions and C3b on Cells Is Impaired in Atypical Hemolytic Uremic Syndrome
- (2009) V. P. Ferreira et al. JOURNAL OF IMMUNOLOGY
- Abnormal platelet function in C3-deficient mice
- (2009) F. C. GUSHIKEN et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Mutations in components of complement influence the outcome of Factor I-associated atypical hemolytic uremic syndrome
- (2009) Frank Bienaime et al. KIDNEY INTERNATIONAL
- The role of the anaphylatoxins in health and disease
- (2009) Andreas Klos et al. MOLECULAR IMMUNOLOGY
- Functional analyses indicate a pathogenic role of factor H autoantibodies in atypical haemolytic uraemic syndrome
- (2009) S. Strobel et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Eculizumab for Atypical Hemolytic–Uremic Syndrome
- (2009) Jens Nürnberger et al. NEW ENGLAND JOURNAL OF MEDICINE
- Eculizumab for Congenital Atypical Hemolytic–Uremic Syndrome
- (2009) Ralph A. Gruppo et al. NEW ENGLAND JOURNAL OF MEDICINE
- Thrombomodulin Mutations in Atypical Hemolytic–Uremic Syndrome
- (2009) Mieke Delvaeye et al. NEW ENGLAND JOURNAL OF MEDICINE
- Atypical Hemolytic–Uremic Syndrome
- (2009) Marina Noris et al. NEW ENGLAND JOURNAL OF MEDICINE
- Complement Mutation-AssociatedDe NovoThrombotic Microangiopathy Following Kidney Transplantation
- (2008) M. Le Quintrec et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Factor H dysfunction in patients with atypical hemolytic uremic syndrome contributes to complement deposition on platelets and their activation
- (2008) A.-l. Stahl et al. BLOOD
- Mutations in complement C3 predispose to development of atypical hemolytic uremic syndrome
- (2008) V. Fremeaux-Bacchi et al. BLOOD
- Von Willebrand factor, ADAMTS13, and thrombotic thrombocytopenic purpura
- (2008) J. E. Sadler BLOOD
- Pexelizumab in ischemic heart disease: A systematic review and meta-analysis on 15,196 patients
- (2008) L. Testa et al. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY
- Membrane cofactor protein mutations in atypical hemolytic uremic syndrome (aHUS), fatal Stx-HUS, C3 glomerulonephritis, and the HELLP syndrome
- (2007) C. J. Fang et al. BLOOD
- Characterization of mutations in complement factor I (CFI) associated with hemolytic uremic syndrome
- (2007) David Kavanagh et al. MOLECULAR IMMUNOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now